Romain Gallet et al. BTS 2016;1:14-28

Slides:

Advertisements

Similar presentations

Candesartan in Heart Failure Presented at European Society of Cardiology 2003 CHARM Trial.

Advertisements

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

American College of Cardiology Foundation/American Heart Association 2009 heart failure staging guidelines. CHF, congestive heart failure; CM, cardiomyopathy;

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Daniel J. Lenihan et al. BTS 2016;1:

Figure 4 Prevalence of HFpEF and HFrEF by age

Nat. Rev. Cardiol. doi: /nrcardio

CIBIS II: Cardiac Insufficiency Bisoprolol Study II

Mirnela Byku, and Douglas L. Mann BTS 2016;1:95-106

Nat. Rev. Cardiol. doi: /nrcardio

Targeted DNA vaccination induced protection against nasal challenge with influenza virus 14 d after DNA vaccination. Targeted DNA vaccination induced protection.

Long-lasting protection against nasal challenge with influenza virus 252 d after a single DNA vaccination. Long-lasting protection against nasal challenge.

TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.

Michael R. Bristow et al. BTS 2018;3:1-8

Romain Gallet et al. BTS 2016;1:14-28

Daniel J. Lenihan et al. BTS 2016;1:

Prf1−/− mice exhibit increased immunopathology with prior CD8 T cell memory secondary to immunization. Prf1−/− mice exhibit increased immunopathology with.

Kaplan–Meier survival curves of all-cause mortality in patients with idiopathic pulmonary fibrosis (IPF). Kaplan–Meier survival curves of all-cause mortality.

Wayne L. Miller et al. JCHF 2013;1:

Nikole J. Byrne et al. BTS 2017;j.jacbts

Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.

Rachel Truitt et al. BTS 2018;3:

Heather M. Wilson et al. BTS 2018;3:

Neal A. Chatterjee et al. JCHF 2014;2:

Romain Gallet et al. BTS 2016;1:14-28

Romain Gallet et al. BTS 2016;1:14-28

Romain Gallet et al. BTS 2016;1:14-28

Fig. 4. Efficacy of C12G6 compared with and in combination with oseltamivir in mice. Efficacy of C12G6 compared with and in combination with oseltamivir.

Romain Gallet et al. BTS 2016;1:14-28

Eduardo Marbán, MD, PhD Mayo Clinic Proceedings

Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

Associations between β-blocker dosage group, predischarge heart rate group, and the primary composite outcome of death or cardiovascular rehospitalisation.

Lauren Brash et al. BTS 2018;3:

UK improves survival. UK improves survival. Following SNx, rats were divided into SNx untreated (disease, n=24; half those remaining were.

Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial.

(A) Mortality in patients with heart failure and different estimated glomerular filtration rate (eGFR) strata, crude survival assessed by Kaplan-Meier.

Nikole J. Byrne et al. BTS 2017;j.jacbts

Microbial communities of the differently treated mice with lupus cluster separately after treatment. Microbial communities of the differently treated mice.

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Figure 3. Survival rates according to renal dysfunction

Stavros V. Konstantinides et al. JACC 2017;69:

Absolute mortality difference Change in LVEF from baseline

Multivariate Cox survival analysis with predictors of mortality after adjusting for comorbidities and DBT. COPD, chronic obstructive pulmonary disease;

Average left ventricular ejection fraction (LVEF) values during the 1 year of observation in patients with preserved systolic function (LVEF >40%) and.

Lifetime heart failure risk*

Anti-hOX40L treatment prevents aGVHD development in NOG mice transplanted with human PBMCs. NOG mice received human PBMCs (1 × 107) via tail vein. animals.

William T. Abraham et al. JCHF 2018;j.jchf

Pro-inflammatory biomarkers in decompensated and stable HFpEF patients

Percentage distribution of ESC HF subtypes and no cardiac dysfunction (no dysf, n=38) among all 370 included patients, where HFvhd is HF due to valvular.

Kaplan-Meier estimate of mortality in the two treatment strategies with significant difference between the two groups (log-rank test

Algorithm for haemodynamic evaluation in the elderly.

Effect of riociguat on a) right heart hypertrophy (assessed by the ratio of right ventricle weight to left ventricle and septum weight (RV/(LV+S)) and.

mTORC1 is required for malignant transformation in the Eμ-Myc model.

Time to first event analysis revealed a significant difference in estimated event-free (death or hospitalisation) survival between patients with left ventricular.

KM analysis of 1-year mortality in the study population stratified according to different baseline characteristics. KM analysis of 1-year mortality in.

The responses of H292 and A549 lung cancer xenografts to hypofractionated radiation were enhanced by the ketogenic diet. The responses of H292 and A549.

Subodh Verma et al. BTS 2018;3:

Molecular Therapy - Nucleic Acids

Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors. Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors.

Survival RR enhancement according to the specific protocol in treated mice. Survival RR enhancement according to the specific protocol in treated mice.

Constantijn Franssen et al. JCHF 2016;4:

Adjusted cumulative incidence of stroke, by sex and heart failure status. Adjusted cumulative incidence of stroke, by sex and heart failure status. The.

ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared with ibrutinib. ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared.

Relationship between 6-month all-cause mortality and the three types of heart failure adjusted for age ≥75 years, peripheral edema at admission, systolic.

Adjusted cumulative disability incidence by sex and heart failure status. Adjusted cumulative disability incidence by sex and heart failure status. The.

Fig. 2. In vivo local CD25-targeted NIR-PIT induces regression of treated LL/2-luc tumors. In vivo local CD25-targeted NIR-PIT induces regression of treated.

Presentation transcript:

Romain Gallet et al. BTS 2016;1:14-28 Effects of CDCs on Mortality and Heart Failure Cardiosphere-derived cell (CDC) treatment improves survival (A; X axis shows days from treatment, or equivalent age in control rats) and pulmonary congestion (B) (lung weight [left] and lung weight/body weight [right]) in rats with heart failure with preserved ejection fraction (HFpEF). (C) At endpoint, body weight loss induced by HFpEF is partially restored by CDC treatment (n = 10 for control rats, n = 15 for placebo-treated rats, and n = 18 for CDC-treated rats). Log-rank for CDCs versus placebo. *p < 0.05 versus placebo- and CDC-treated rats, †p < 0.05 versus control and CDC-treated rats, and ‡p < 0.05 versus placebo-treated rats, all by analysis of variance. ttt = treatment. Romain Gallet et al. BTS 2016;1:14-28 The Authors